Cargando…
Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic
PURPOSE: The aim of this study was to assess the impact of repurposing health care facilities in response to COVID-19 on the access of patients with thyroid disease to health care. METHODS: This study consisted of a web-based survey. The survey was anonymous and consisted of forty questions. RESULTS...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944403/ https://www.ncbi.nlm.nih.gov/pubmed/35325447 http://dx.doi.org/10.1007/s40618-022-01787-6 |
_version_ | 1784673706481549312 |
---|---|
author | Žarković, M. Perros, P. Ćirić, J. Beleslin, B. Stojanović, M. Stojković, M. Miletić, M. Janić, T. |
author_facet | Žarković, M. Perros, P. Ćirić, J. Beleslin, B. Stojanović, M. Stojković, M. Miletić, M. Janić, T. |
author_sort | Žarković, M. |
collection | PubMed |
description | PURPOSE: The aim of this study was to assess the impact of repurposing health care facilities in response to COVID-19 on the access of patients with thyroid disease to health care. METHODS: This study consisted of a web-based survey. The survey was anonymous and consisted of forty questions. RESULTS: This survey included 206 respondents. 91.3% of the respondents had health insurance through the Republic Fund of Health Insurance, 9.7% had private or both health insurances, and 3.4% did not have any health insurance. A significant proportion of respondents (60.4%) had to switch from public to private health care to reach a physician and 73.8% had to switch from public to private laboratories. For the 91.9%, this was perceived as a financial burden. Before the pandemic, 83.1% of respondents reported regular follow-up by physicians, which decreased to 44.9% during the pandemic (p < 0.01). 76.3% of the respondents regarded that their thyroid disease was managed optimally before the pandemic, while this figure declined to only 48% during the pandemic (p < 0.01). CONCLUSIONS: The COVID-19 pandemic disrupted the medical care of thyroid patients in Serbia. For the patients treated in the public health care system, access to general practice was hindered, while access to specialist care was disrupted. It led to a switch from public to private health care, which was perceived as a financial burden for almost all the respondents. However, private health care proved to be an important safety net when the public system was overwhelmed. |
format | Online Article Text |
id | pubmed-8944403 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-89444032022-03-24 Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic Žarković, M. Perros, P. Ćirić, J. Beleslin, B. Stojanović, M. Stojković, M. Miletić, M. Janić, T. J Endocrinol Invest Original Article PURPOSE: The aim of this study was to assess the impact of repurposing health care facilities in response to COVID-19 on the access of patients with thyroid disease to health care. METHODS: This study consisted of a web-based survey. The survey was anonymous and consisted of forty questions. RESULTS: This survey included 206 respondents. 91.3% of the respondents had health insurance through the Republic Fund of Health Insurance, 9.7% had private or both health insurances, and 3.4% did not have any health insurance. A significant proportion of respondents (60.4%) had to switch from public to private health care to reach a physician and 73.8% had to switch from public to private laboratories. For the 91.9%, this was perceived as a financial burden. Before the pandemic, 83.1% of respondents reported regular follow-up by physicians, which decreased to 44.9% during the pandemic (p < 0.01). 76.3% of the respondents regarded that their thyroid disease was managed optimally before the pandemic, while this figure declined to only 48% during the pandemic (p < 0.01). CONCLUSIONS: The COVID-19 pandemic disrupted the medical care of thyroid patients in Serbia. For the patients treated in the public health care system, access to general practice was hindered, while access to specialist care was disrupted. It led to a switch from public to private health care, which was perceived as a financial burden for almost all the respondents. However, private health care proved to be an important safety net when the public system was overwhelmed. Springer International Publishing 2022-03-24 2022 /pmc/articles/PMC8944403/ /pubmed/35325447 http://dx.doi.org/10.1007/s40618-022-01787-6 Text en © The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE) 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Žarković, M. Perros, P. Ćirić, J. Beleslin, B. Stojanović, M. Stojković, M. Miletić, M. Janić, T. Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic |
title | Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic |
title_full | Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic |
title_fullStr | Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic |
title_full_unstemmed | Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic |
title_short | Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic |
title_sort | health care access of thyroid disease patients in serbia during the covid-19 pandemic |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944403/ https://www.ncbi.nlm.nih.gov/pubmed/35325447 http://dx.doi.org/10.1007/s40618-022-01787-6 |
work_keys_str_mv | AT zarkovicm healthcareaccessofthyroiddiseasepatientsinserbiaduringthecovid19pandemic AT perrosp healthcareaccessofthyroiddiseasepatientsinserbiaduringthecovid19pandemic AT ciricj healthcareaccessofthyroiddiseasepatientsinserbiaduringthecovid19pandemic AT beleslinb healthcareaccessofthyroiddiseasepatientsinserbiaduringthecovid19pandemic AT stojanovicm healthcareaccessofthyroiddiseasepatientsinserbiaduringthecovid19pandemic AT stojkovicm healthcareaccessofthyroiddiseasepatientsinserbiaduringthecovid19pandemic AT mileticm healthcareaccessofthyroiddiseasepatientsinserbiaduringthecovid19pandemic AT janict healthcareaccessofthyroiddiseasepatientsinserbiaduringthecovid19pandemic |